173 related articles for article (PubMed ID: 7578764)
1. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients.
Rooney G; Nelson MR; Gazzard B
J Clin Pathol; 1996 Oct; 49(10):821-3. PubMed ID: 8943748
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
Shafer RW; Sierra MF
Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium.
Bamberger DM; Driks MR; Gupta MR; O'Connor MC; Jost PM; Neihart RE; McKinsey DS; Moore LA
Clin Infect Dis; 1994 Mar; 18(3):395-400. PubMed ID: 8011822
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
Levine B; Chaisson RE
Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus.
Carpenter JL; Parks JM
Rev Infect Dis; 1991; 13(5):789-96. PubMed ID: 1962086
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.
Pechère M; Opravil M; Wald A; Chave JP; Bessesen M; Sievers A; Hein R; von Overbeck J; Clark RA; Tortoli E
Arch Intern Med; 1995 Feb; 155(4):400-4. PubMed ID: 7848023
[TBL] [Abstract][Full Text] [Related]
8. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
[TBL] [Abstract][Full Text] [Related]
9. Pyogenic abscess caused by Mycobacterium kansasii in advanced AIDS.
Mandal D; Curless E; Ostick DG
Int J STD AIDS; 1992; 3(5):362-3. PubMed ID: 1391065
[No Abstract] [Full Text] [Related]
10. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
[TBL] [Abstract][Full Text] [Related]
11. [Disseminated infection by Mycobacterium scrofulaceum: apropos of 3 cases].
Campos-Herrero MI; Rodríguez H; Lluch J; Perdomo M; Pérez MC; Gómez E
Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):258-60. PubMed ID: 9044643
[TBL] [Abstract][Full Text] [Related]
12. Oral manifestation of disseminated Mycobacterium kansasii infection in a patient with AIDS.
Nüesch R; Battegay M; Zimmerli W; Thumshirn M; Gilli L; Itin PH
Dermatology; 1996; 192(2):183-4. PubMed ID: 8829510
[TBL] [Abstract][Full Text] [Related]
13. Disseminated Mycobacterium kansasii infection presenting as pneumonia and osteomyelitis of the skull in a patient with AIDS.
Weinroth SE; Pincetl P; Tuazon CU
Clin Infect Dis; 1994 Feb; 18(2):261-2. PubMed ID: 8161645
[No Abstract] [Full Text] [Related]
14. [Mycobacterium kansasii infection in patients with human immunodeficiency virus infection].
Boudon P; Le Pennec MP; Malbec D; Mathieu M; Slama JL; Manet P; Pines E; Kretz S; Giacomini T
Rev Med Interne; 1995; 16(10):747-51. PubMed ID: 8525154
[TBL] [Abstract][Full Text] [Related]
15. Species distribution in human immunodeficiency virus-related mycobacterial infections: implications for selection of initial treatment.
Montessori V; Phillips P; Montaner J; Haley L; Craib K; Bessuille E; Black W
Clin Infect Dis; 1996 Jun; 22(6):989-92. PubMed ID: 8783698
[TBL] [Abstract][Full Text] [Related]
16. [Disease caused by Mycobacterium kansasii in patients with HIV infection].
Urkijo JC; Montejo M; Aguirrebengoa K; Urra E; Aguirre C
Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):120-5. PubMed ID: 8499509
[TBL] [Abstract][Full Text] [Related]
17. Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome.
Tenholder MF; Moser RJ; Tellis CJ
Arch Intern Med; 1988 Apr; 148(4):953-5. PubMed ID: 3355312
[TBL] [Abstract][Full Text] [Related]
18. Nontuberculous mycobacterial infections.
French AL; Benator DA; Gordin FM
Med Clin North Am; 1997 Mar; 81(2):361-79. PubMed ID: 9093233
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of reformulated chemiluminescent DNA probe (AccuProbe) for culture identification of Mycobacterium kansasii.
Tortoli E; Simonetti MT; Lavinia F
J Clin Microbiol; 1996 Nov; 34(11):2838-40. PubMed ID: 8897195
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
